June 12, 2024 Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 months Digital measures may provide objective, sensitive, real-world measures of disease progression in Parkinson’s disease (PD).
June 12, 2024 C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing Smartwatches to Monitor Disease Progression Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology...
June 10, 2024 Advocate Sarah Dolan Brings a Patient Voice to FDA Committee Reviewing New Alzheimer’s Drug Donanemab On Monday, June 10, the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory...
June 5, 2024 eCOA Masterclass #1: The Road to Best Practice Consensus: Electronic Migration and Implementation of PRO Measures Join the co-authors of the published article in Value in Health for a deep dive into existing and current best practices for the..
June 3, 2024-June 6, 2024 Connect with C-Path at BIO 2024: Join us on the path forward in drug development C-Path CEO Klaus Romero will be a panelist in two sessions at the upcoming BIO 2024 Conference. In two featured sessions...
May 30, 2024 C-Path Supports Gleason, ALS Community at IgNight ALS The C-Path team was incredibly humbled to be a part of IgNight ALS recently in Washington, D.C., honoring Steve Gleason and celebr
May 28, 2024 Accelerating healthcare innovation: the role of Artificial intelligence and digital health technologies in critical path institute’s public-private partnerships Artificial Intelligence (AI) and Digital Health Technologies (DHTs) are radically transforming drug development. The FDA and EMA..
May 23, 2024 Webinar: The Use and Development of DHTs with Patient Advocacy Groups Join C-Path and Dr. Laurent Servais for an overview of Actimyo and relevant learnings...
May 23, 2024 C-Path’s RDCA-DAP Webinar, “The Use and Development of DHTs with Patient Advocacy Groups” a Hit, with Keynote, Patient Advocacy Panel, and Engaged QAs Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), part of C-Path's Rare...
May 22, 2024 C-Path Roundtable: Help4HD Unites to Discuss Advancements in Huntington’s Disease Treatments "My husband passed away with no therapies, no treatments that worked for him, and it took away his quality of life...
